Ligand Pharmaceuticals (LGND) EBT Margin (2010 - 2026)
Ligand Pharmaceuticals (LGND) reported EBT Margin of 100.96% for Q2 2026, up 77.39 percentage points from 23.56% a year earlier and up 147.86 percentage points from the prior quarter.
Powered by 
Analysis
Ligand Pharmaceuticals (LGND) EBT Margin (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Ligand Pharmaceuticals' EBT Margin came in at 81.90%, up 126.95 percentage points year-over-year; for FY2025, it was 59.29%, up 57.79 percentage points from FY2024.
- EBT Margin has a five-year change of +58.50 percentage points (FY2020 to FY2025).
- By year, EBT Margin came in at 1.51% in FY2024 (-46.97 pp), 48.48% in FY2023 (+30.13 pp), 18.35% in FY2022 (-11.54 pp) and 29.89% in FY2021 (+29.10 pp).
- Five-year quarterly EBT Margin spans a low of -157.45% in Q2 2024 and a high of 366.22% in Q1 2024.
- Year over year, EBT Margin has now increased in each of the last five quarters, with an average year-over-year change of +4.85 percentage points over the last eight quarters.
- The high point for year-over-year EBT Margin in five years was Q1 2024 (a gain of 239.94 percentage points); the low point was Q1 2025 (a drop of 476.91 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -46.90% (Q1 2026), 95.16% (Q4 2025) and 122.24% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 41.75% |
| 10 | Ligand Pharmaceuticals | 6.26 Bn | 2.72 Bn | - | 100.96% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 100.96% |
| Mar 31, 2026 | -46.90% |
| Dec 31, 2025 | 95.16% |
| Sep 30, 2025 | 122.24% |
| Jun 30, 2025 | 23.56% |
| Mar 31, 2025 | -110.69% |
| Dec 31, 2024 | -91.56% |
| Sep 30, 2024 | -12.23% |
| Jun 30, 2024 | -157.45% |
| Mar 31, 2024 | 366.22% |
| Dec 31, 2023 | 60.84% |
| Sep 30, 2023 | -36.95% |
| Jun 30, 2023 | 12.03% |
| Mar 31, 2023 | 126.28% |
| Dec 31, 2022 | 47.91% |
| Sep 30, 2022 | 20.86% |
| Jun 30, 2022 | 17.28% |
| Mar 31, 2022 | -25.04% |
| Dec 31, 2021 | 31.70% |
| Sep 30, 2021 | 25.56% |
API Access
Ligand Pharmaceuticals EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=LGND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "LGND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=LGND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();